Sign Up to like & get
recommendations!
1
Published in 2020 at "Immunology"
DOI: 10.1158/1538-7445.am2020-6658
Abstract: Background: In the context of novel immuno-oncology therapeutics development at preclinical stage, it9s crucial to understand the primary features of the in-vivo model to be used and to delineate mechanisms underlying response to a drug…
read more here.
Keywords:
model sarcoma;
anti pdl1;
effect;
model ... See more keywords